nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Visual impairment—Ifosfamide—germ cell cancer	0.00338	0.00338	CcSEcCtD
Gemifloxacin—Erythema multiforme—Ifosfamide—germ cell cancer	0.00332	0.00332	CcSEcCtD
Gemifloxacin—Renal failure—Cisplatin—germ cell cancer	0.00331	0.00331	CcSEcCtD
Gemifloxacin—Vaginal inflammation—Methotrexate—germ cell cancer	0.00331	0.00331	CcSEcCtD
Gemifloxacin—Anaemia—Bleomycin—germ cell cancer	0.0033	0.0033	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Cisplatin—germ cell cancer	0.0033	0.0033	CcSEcCtD
Gemifloxacin—Anorexia—Vinblastine—germ cell cancer	0.00329	0.00329	CcSEcCtD
Gemifloxacin—Stomatitis—Cisplatin—germ cell cancer	0.00329	0.00329	CcSEcCtD
Gemifloxacin—Eye disorder—Ifosfamide—germ cell cancer	0.00328	0.00328	CcSEcCtD
Gemifloxacin—Cardiac disorder—Ifosfamide—germ cell cancer	0.00326	0.00326	CcSEcCtD
Gemifloxacin—Flushing—Ifosfamide—germ cell cancer	0.00326	0.00326	CcSEcCtD
Gemifloxacin—Leukopenia—Bleomycin—germ cell cancer	0.0032	0.0032	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00319	0.00319	CcSEcCtD
Gemifloxacin—Angiopathy—Ifosfamide—germ cell cancer	0.00319	0.00319	CcSEcCtD
Gemifloxacin—Immune system disorder—Ifosfamide—germ cell cancer	0.00317	0.00317	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00316	0.00316	CcSEcCtD
Gemifloxacin—Skin exfoliation—Methotrexate—germ cell cancer	0.00316	0.00316	CcSEcCtD
Gemifloxacin—Vaginal infection—Methotrexate—germ cell cancer	0.00312	0.00312	CcSEcCtD
Gemifloxacin—Pneumonia—Etoposide—germ cell cancer	0.00311	0.00311	CcSEcCtD
Gemifloxacin—Infestation NOS—Etoposide—germ cell cancer	0.00309	0.00309	CcSEcCtD
Gemifloxacin—Infestation—Etoposide—germ cell cancer	0.00309	0.00309	CcSEcCtD
Gemifloxacin—Anaemia—Dactinomycin—germ cell cancer	0.00308	0.00308	CcSEcCtD
Gemifloxacin—Mental disorder—Ifosfamide—germ cell cancer	0.00308	0.00308	CcSEcCtD
Gemifloxacin—Myalgia—Bleomycin—germ cell cancer	0.00304	0.00304	CcSEcCtD
Gemifloxacin—Renal failure—Etoposide—germ cell cancer	0.00304	0.00304	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Etoposide—germ cell cancer	0.00303	0.00303	CcSEcCtD
Gemifloxacin—Stomatitis—Etoposide—germ cell cancer	0.00301	0.00301	CcSEcCtD
Gemifloxacin—Decreased appetite—Vinblastine—germ cell cancer	0.003	0.003	CcSEcCtD
Gemifloxacin—Mouth ulceration—Methotrexate—germ cell cancer	0.00299	0.00299	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Cisplatin—germ cell cancer	0.00299	0.00299	CcSEcCtD
Gemifloxacin—Leukopenia—Dactinomycin—germ cell cancer	0.00299	0.00299	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Cisplatin—germ cell cancer	0.00297	0.00297	CcSEcCtD
Gemifloxacin—Urethral disorder—Cisplatin—germ cell cancer	0.00297	0.00297	CcSEcCtD
Gemifloxacin—Pain—Vinblastine—germ cell cancer	0.00295	0.00295	CcSEcCtD
Gemifloxacin—Constipation—Vinblastine—germ cell cancer	0.00295	0.00295	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Etoposide—germ cell cancer	0.00292	0.00292	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Bleomycin—germ cell cancer	0.00292	0.00292	CcSEcCtD
Gemifloxacin—Oedema—Bleomycin—germ cell cancer	0.00292	0.00292	CcSEcCtD
Gemifloxacin—Visual impairment—Cisplatin—germ cell cancer	0.00292	0.00292	CcSEcCtD
Gemifloxacin—Agranulocytosis—Etoposide—germ cell cancer	0.00288	0.00288	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Bleomycin—germ cell cancer	0.00286	0.00286	CcSEcCtD
Gemifloxacin—Myalgia—Dactinomycin—germ cell cancer	0.00284	0.00284	CcSEcCtD
Gemifloxacin—Eye disorder—Cisplatin—germ cell cancer	0.00283	0.00283	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00283	0.00283	CcSEcCtD
Gemifloxacin—Anaemia—Ifosfamide—germ cell cancer	0.00282	0.00282	CcSEcCtD
Gemifloxacin—Flushing—Cisplatin—germ cell cancer	0.00281	0.00281	CcSEcCtD
Gemifloxacin—Cardiac disorder—Cisplatin—germ cell cancer	0.00281	0.00281	CcSEcCtD
Gemifloxacin—Anorexia—Bleomycin—germ cell cancer	0.00278	0.00278	CcSEcCtD
Gemifloxacin—Vertigo—Ifosfamide—germ cell cancer	0.00275	0.00275	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Etoposide—germ cell cancer	0.00274	0.00274	CcSEcCtD
Gemifloxacin—Leukopenia—Ifosfamide—germ cell cancer	0.00274	0.00274	CcSEcCtD
Gemifloxacin—Photosensitivity—Methotrexate—germ cell cancer	0.00273	0.00273	CcSEcCtD
Gemifloxacin—Immune system disorder—Cisplatin—germ cell cancer	0.00273	0.00273	CcSEcCtD
Gemifloxacin—Abdominal pain—Vinblastine—germ cell cancer	0.00273	0.00273	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Cisplatin—germ cell cancer	0.00273	0.00273	CcSEcCtD
Gemifloxacin—Oedema—Dactinomycin—germ cell cancer	0.00272	0.00272	CcSEcCtD
Gemifloxacin—Urethral disorder—Etoposide—germ cell cancer	0.00272	0.00272	CcSEcCtD
Gemifloxacin—Palpitations—Ifosfamide—germ cell cancer	0.0027	0.0027	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00266	0.00266	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00266	0.00266	CcSEcCtD
Gemifloxacin—Erythema multiforme—Etoposide—germ cell cancer	0.00262	0.00262	CcSEcCtD
Gemifloxacin—Dyspnoea—Bleomycin—germ cell cancer	0.0026	0.0026	CcSEcCtD
Gemifloxacin—Myalgia—Ifosfamide—germ cell cancer	0.0026	0.0026	CcSEcCtD
Gemifloxacin—Arthralgia—Ifosfamide—germ cell cancer	0.0026	0.0026	CcSEcCtD
Gemifloxacin—Renal failure acute—Methotrexate—germ cell cancer	0.0026	0.0026	CcSEcCtD
Gemifloxacin—Flatulence—Cisplatin—germ cell cancer	0.0026	0.0026	CcSEcCtD
Gemifloxacin—Anorexia—Dactinomycin—germ cell cancer	0.00259	0.00259	CcSEcCtD
Gemifloxacin—Eye disorder—Etoposide—germ cell cancer	0.00259	0.00259	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00258	0.00258	CcSEcCtD
Gemifloxacin—Flushing—Etoposide—germ cell cancer	0.00257	0.00257	CcSEcCtD
Gemifloxacin—Cardiac disorder—Etoposide—germ cell cancer	0.00257	0.00257	CcSEcCtD
Gemifloxacin—Decreased appetite—Bleomycin—germ cell cancer	0.00254	0.00254	CcSEcCtD
Gemifloxacin—Muscle spasms—Cisplatin—germ cell cancer	0.00253	0.00253	CcSEcCtD
Gemifloxacin—Angiopathy—Etoposide—germ cell cancer	0.00252	0.00252	CcSEcCtD
Gemifloxacin—Immune system disorder—Etoposide—germ cell cancer	0.0025	0.0025	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Etoposide—germ cell cancer	0.0025	0.0025	CcSEcCtD
Gemifloxacin—Pain—Bleomycin—germ cell cancer	0.0025	0.0025	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00249	0.00249	CcSEcCtD
Gemifloxacin—Oedema—Ifosfamide—germ cell cancer	0.00249	0.00249	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00248	0.00248	CcSEcCtD
Gemifloxacin—Asthenia—Vinblastine—germ cell cancer	0.00248	0.00248	CcSEcCtD
Gemifloxacin—Tremor—Cisplatin—germ cell cancer	0.00247	0.00247	CcSEcCtD
Gemifloxacin—Nervous system disorder—Ifosfamide—germ cell cancer	0.00245	0.00245	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00244	0.00244	CcSEcCtD
Gemifloxacin—Anaemia—Cisplatin—germ cell cancer	0.00244	0.00244	CcSEcCtD
Gemifloxacin—Skin disorder—Ifosfamide—germ cell cancer	0.00242	0.00242	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00241	0.00241	CcSEcCtD
Gemifloxacin—Anorexia—Ifosfamide—germ cell cancer	0.00238	0.00238	CcSEcCtD
Gemifloxacin—Decreased appetite—Dactinomycin—germ cell cancer	0.00237	0.00237	CcSEcCtD
Gemifloxacin—Diarrhoea—Vinblastine—germ cell cancer	0.00236	0.00236	CcSEcCtD
Gemifloxacin—Dysgeusia—Etoposide—germ cell cancer	0.00236	0.00236	CcSEcCtD
Gemifloxacin—Leukopenia—Cisplatin—germ cell cancer	0.00236	0.00236	CcSEcCtD
Gemifloxacin—Fatigue—Dactinomycin—germ cell cancer	0.00235	0.00235	CcSEcCtD
Gemifloxacin—Back pain—Etoposide—germ cell cancer	0.00233	0.00233	CcSEcCtD
Gemifloxacin—Pain—Dactinomycin—germ cell cancer	0.00233	0.00233	CcSEcCtD
Gemifloxacin—Muscle spasms—Etoposide—germ cell cancer	0.00232	0.00232	CcSEcCtD
Gemifloxacin—Urticaria—Bleomycin—germ cell cancer	0.00232	0.00232	CcSEcCtD
Gemifloxacin—Body temperature increased—Bleomycin—germ cell cancer	0.00231	0.00231	CcSEcCtD
Gemifloxacin—Dizziness—Vinblastine—germ cell cancer	0.00228	0.00228	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00227	0.00227	CcSEcCtD
Gemifloxacin—Myalgia—Cisplatin—germ cell cancer	0.00224	0.00224	CcSEcCtD
Gemifloxacin—Anaemia—Etoposide—germ cell cancer	0.00223	0.00223	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00223	0.00223	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00223	0.00223	CcSEcCtD
Gemifloxacin—Dyspnoea—Ifosfamide—germ cell cancer	0.00222	0.00222	CcSEcCtD
Gemifloxacin—Somnolence—Ifosfamide—germ cell cancer	0.00222	0.00222	CcSEcCtD
Gemifloxacin—Vomiting—Vinblastine—germ cell cancer	0.0022	0.0022	CcSEcCtD
Gemifloxacin—Breast disorder—Methotrexate—germ cell cancer	0.00217	0.00217	CcSEcCtD
Gemifloxacin—Vertigo—Etoposide—germ cell cancer	0.00217	0.00217	CcSEcCtD
Gemifloxacin—Decreased appetite—Ifosfamide—germ cell cancer	0.00217	0.00217	CcSEcCtD
Gemifloxacin—Headache—Vinblastine—germ cell cancer	0.00216	0.00216	CcSEcCtD
Gemifloxacin—Leukopenia—Etoposide—germ cell cancer	0.00216	0.00216	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00215	0.00215	CcSEcCtD
Gemifloxacin—Abdominal pain—Dactinomycin—germ cell cancer	0.00215	0.00215	CcSEcCtD
Gemifloxacin—Body temperature increased—Dactinomycin—germ cell cancer	0.00215	0.00215	CcSEcCtD
Gemifloxacin—Fatigue—Ifosfamide—germ cell cancer	0.00215	0.00215	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Cisplatin—germ cell cancer	0.00215	0.00215	CcSEcCtD
Gemifloxacin—Oedema—Cisplatin—germ cell cancer	0.00215	0.00215	CcSEcCtD
Gemifloxacin—Constipation—Ifosfamide—germ cell cancer	0.00213	0.00213	CcSEcCtD
Gemifloxacin—Pain—Ifosfamide—germ cell cancer	0.00213	0.00213	CcSEcCtD
Gemifloxacin—Loss of consciousness—Etoposide—germ cell cancer	0.00212	0.00212	CcSEcCtD
Gemifloxacin—Nervous system disorder—Cisplatin—germ cell cancer	0.00211	0.00211	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Cisplatin—germ cell cancer	0.00211	0.00211	CcSEcCtD
Gemifloxacin—Tachycardia—Cisplatin—germ cell cancer	0.0021	0.0021	CcSEcCtD
Gemifloxacin—Asthenia—Bleomycin—germ cell cancer	0.00209	0.00209	CcSEcCtD
Gemifloxacin—Skin disorder—Cisplatin—germ cell cancer	0.00209	0.00209	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Cisplatin—germ cell cancer	0.00208	0.00208	CcSEcCtD
Gemifloxacin—Pruritus—Bleomycin—germ cell cancer	0.00206	0.00206	CcSEcCtD
Gemifloxacin—Eosinophilia—Methotrexate—germ cell cancer	0.00205	0.00205	CcSEcCtD
Gemifloxacin—Nausea—Vinblastine—germ cell cancer	0.00205	0.00205	CcSEcCtD
Gemifloxacin—Anorexia—Cisplatin—germ cell cancer	0.00205	0.00205	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00204	0.00204	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00204	0.00204	CcSEcCtD
Gemifloxacin—Pancreatitis—Methotrexate—germ cell cancer	0.00203	0.00203	CcSEcCtD
Gemifloxacin—Urticaria—Ifosfamide—germ cell cancer	0.00198	0.00198	CcSEcCtD
Gemifloxacin—Abdominal pain—Ifosfamide—germ cell cancer	0.00197	0.00197	CcSEcCtD
Gemifloxacin—Body temperature increased—Ifosfamide—germ cell cancer	0.00197	0.00197	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Etoposide—germ cell cancer	0.00197	0.00197	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Gemifloxacin—Asthenia—Dactinomycin—germ cell cancer	0.00195	0.00195	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Etoposide—germ cell cancer	0.00193	0.00193	CcSEcCtD
Gemifloxacin—Tachycardia—Etoposide—germ cell cancer	0.00192	0.00192	CcSEcCtD
Gemifloxacin—Dyspnoea—Cisplatin—germ cell cancer	0.00192	0.00192	CcSEcCtD
Gemifloxacin—Skin disorder—Etoposide—germ cell cancer	0.00191	0.00191	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Etoposide—germ cell cancer	0.0019	0.0019	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Methotrexate—germ cell cancer	0.00189	0.00189	CcSEcCtD
Gemifloxacin—Anorexia—Etoposide—germ cell cancer	0.00188	0.00188	CcSEcCtD
Gemifloxacin—Decreased appetite—Cisplatin—germ cell cancer	0.00187	0.00187	CcSEcCtD
Gemifloxacin—Diarrhoea—Dactinomycin—germ cell cancer	0.00186	0.00186	CcSEcCtD
Gemifloxacin—Pneumonia—Methotrexate—germ cell cancer	0.00186	0.00186	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00186	0.00186	CcSEcCtD
Gemifloxacin—Vomiting—Bleomycin—germ cell cancer	0.00186	0.00186	CcSEcCtD
Gemifloxacin—Infestation—Methotrexate—germ cell cancer	0.00185	0.00185	CcSEcCtD
Gemifloxacin—Infestation NOS—Methotrexate—germ cell cancer	0.00185	0.00185	CcSEcCtD
Gemifloxacin—Rash—Bleomycin—germ cell cancer	0.00184	0.00184	CcSEcCtD
Gemifloxacin—Pain—Cisplatin—germ cell cancer	0.00184	0.00184	CcSEcCtD
Gemifloxacin—Dermatitis—Bleomycin—germ cell cancer	0.00184	0.00184	CcSEcCtD
Gemifloxacin—Renal failure—Methotrexate—germ cell cancer	0.00182	0.00182	CcSEcCtD
Gemifloxacin—Stomatitis—Methotrexate—germ cell cancer	0.0018	0.0018	CcSEcCtD
Gemifloxacin—Asthenia—Ifosfamide—germ cell cancer	0.00179	0.00179	CcSEcCtD
Gemifloxacin—Pruritus—Ifosfamide—germ cell cancer	0.00176	0.00176	CcSEcCtD
Gemifloxacin—Haematuria—Methotrexate—germ cell cancer	0.00176	0.00176	CcSEcCtD
Gemifloxacin—Dyspnoea—Etoposide—germ cell cancer	0.00176	0.00176	CcSEcCtD
Gemifloxacin—Somnolence—Etoposide—germ cell cancer	0.00175	0.00175	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00175	0.00175	CcSEcCtD
Gemifloxacin—Nausea—Bleomycin—germ cell cancer	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Vomiting—Dactinomycin—germ cell cancer	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Agranulocytosis—Methotrexate—germ cell cancer	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Rash—Dactinomycin—germ cell cancer	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Decreased appetite—Etoposide—germ cell cancer	0.00171	0.00171	CcSEcCtD
Gemifloxacin—Diarrhoea—Ifosfamide—germ cell cancer	0.00171	0.00171	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Etoposide—germ cell cancer	0.0017	0.0017	CcSEcCtD
Gemifloxacin—Body temperature increased—Cisplatin—germ cell cancer	0.0017	0.0017	CcSEcCtD
Gemifloxacin—Fatigue—Etoposide—germ cell cancer	0.0017	0.0017	CcSEcCtD
Gemifloxacin—Pain—Etoposide—germ cell cancer	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Constipation—Etoposide—germ cell cancer	0.00168	0.00168	CcSEcCtD
Gemifloxacin—Haemoglobin—Methotrexate—germ cell cancer	0.00167	0.00167	CcSEcCtD
Gemifloxacin—Haemorrhage—Methotrexate—germ cell cancer	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Dizziness—Ifosfamide—germ cell cancer	0.00165	0.00165	CcSEcCtD
Gemifloxacin—Pharyngitis—Methotrexate—germ cell cancer	0.00165	0.00165	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Methotrexate—germ cell cancer	0.00164	0.00164	CcSEcCtD
Gemifloxacin—Urethral disorder—Methotrexate—germ cell cancer	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Nausea—Dactinomycin—germ cell cancer	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Etoposide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Gemifloxacin—Visual impairment—Methotrexate—germ cell cancer	0.0016	0.0016	CcSEcCtD
Gemifloxacin—Vomiting—Ifosfamide—germ cell cancer	0.00159	0.00159	CcSEcCtD
Gemifloxacin—Rash—Ifosfamide—germ cell cancer	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Dermatitis—Ifosfamide—germ cell cancer	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Erythema multiforme—Methotrexate—germ cell cancer	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Urticaria—Etoposide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Abdominal pain—Etoposide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Body temperature increased—Etoposide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Eye disorder—Methotrexate—germ cell cancer	0.00155	0.00155	CcSEcCtD
Gemifloxacin—Asthenia—Cisplatin—germ cell cancer	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Cardiac disorder—Methotrexate—germ cell cancer	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Angiopathy—Methotrexate—germ cell cancer	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Immune system disorder—Methotrexate—germ cell cancer	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methotrexate—germ cell cancer	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Nausea—Ifosfamide—germ cell cancer	0.00148	0.00148	CcSEcCtD
Gemifloxacin—Diarrhoea—Cisplatin—germ cell cancer	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Mental disorder—Methotrexate—germ cell cancer	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Dysgeusia—Methotrexate—germ cell cancer	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Asthenia—Etoposide—germ cell cancer	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Back pain—Methotrexate—germ cell cancer	0.0014	0.0014	CcSEcCtD
Gemifloxacin—Pruritus—Etoposide—germ cell cancer	0.00139	0.00139	CcSEcCtD
Gemifloxacin—Vomiting—Cisplatin—germ cell cancer	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Rash—Cisplatin—germ cell cancer	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Dermatitis—Cisplatin—germ cell cancer	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Diarrhoea—Etoposide—germ cell cancer	0.00135	0.00135	CcSEcCtD
Gemifloxacin—Anaemia—Methotrexate—germ cell cancer	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Dizziness—Etoposide—germ cell cancer	0.0013	0.0013	CcSEcCtD
Gemifloxacin—Vertigo—Methotrexate—germ cell cancer	0.0013	0.0013	CcSEcCtD
Gemifloxacin—Leukopenia—Methotrexate—germ cell cancer	0.00129	0.00129	CcSEcCtD
Gemifloxacin—Nausea—Cisplatin—germ cell cancer	0.00128	0.00128	CcSEcCtD
Gemifloxacin—Vomiting—Etoposide—germ cell cancer	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Rash—Etoposide—germ cell cancer	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Dermatitis—Etoposide—germ cell cancer	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Headache—Etoposide—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Arthralgia—Methotrexate—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Myalgia—Methotrexate—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00122	0.00122	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methotrexate—germ cell cancer	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Nausea—Etoposide—germ cell cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methotrexate—germ cell cancer	0.00116	0.00116	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Methotrexate—germ cell cancer	0.00116	0.00116	CcSEcCtD
Gemifloxacin—Skin disorder—Methotrexate—germ cell cancer	0.00115	0.00115	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methotrexate—germ cell cancer	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Anorexia—Methotrexate—germ cell cancer	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Insomnia—Methotrexate—germ cell cancer	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Dyspnoea—Methotrexate—germ cell cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Somnolence—Methotrexate—germ cell cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Dyspepsia—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Decreased appetite—Methotrexate—germ cell cancer	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Fatigue—Methotrexate—germ cell cancer	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Pain—Methotrexate—germ cell cancer	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000965	0.000965	CcSEcCtD
Gemifloxacin—Urticaria—Methotrexate—germ cell cancer	0.000937	0.000937	CcSEcCtD
Gemifloxacin—Abdominal pain—Methotrexate—germ cell cancer	0.000933	0.000933	CcSEcCtD
Gemifloxacin—Body temperature increased—Methotrexate—germ cell cancer	0.000933	0.000933	CcSEcCtD
Gemifloxacin—Asthenia—Methotrexate—germ cell cancer	0.000847	0.000847	CcSEcCtD
Gemifloxacin—Pruritus—Methotrexate—germ cell cancer	0.000835	0.000835	CcSEcCtD
Gemifloxacin—Diarrhoea—Methotrexate—germ cell cancer	0.000807	0.000807	CcSEcCtD
Gemifloxacin—Dizziness—Methotrexate—germ cell cancer	0.00078	0.00078	CcSEcCtD
Gemifloxacin—Vomiting—Methotrexate—germ cell cancer	0.00075	0.00075	CcSEcCtD
Gemifloxacin—Rash—Methotrexate—germ cell cancer	0.000744	0.000744	CcSEcCtD
Gemifloxacin—Dermatitis—Methotrexate—germ cell cancer	0.000743	0.000743	CcSEcCtD
Gemifloxacin—Headache—Methotrexate—germ cell cancer	0.000739	0.000739	CcSEcCtD
Gemifloxacin—Nausea—Methotrexate—germ cell cancer	0.000701	0.000701	CcSEcCtD
